Last reviewed · How we verify
Standard reference therapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard reference therapy (Standard reference therapy) — Johns Hopkins Bloomberg School of Public Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard reference therapy TARGET | Standard reference therapy | Johns Hopkins Bloomberg School of Public Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard reference therapy CI watch — RSS
- Standard reference therapy CI watch — Atom
- Standard reference therapy CI watch — JSON
- Standard reference therapy alone — RSS
Cite this brief
Drug Landscape (2026). Standard reference therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-reference-therapy. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab